Sanne Wass
-
The Ozempic Effect: How A Weight Loss Wonder Drug Gobbled Up An Entire Economy
The blockbuster drug producer is Europe’s most valuable company —and its home country is feeling the effects.
-
Shipping Bosses Warn Maritime Security In Red Sea Getting Worse Not Better
Major shipping companies are warning that the security situation in the Red Sea is continuing to deteriorate, despite efforts by the west to limit attacks by Yemen’s Houthi rebels.
-
To Cut Food Waste, Supermarkets Turn to AI to Sell Near-Expired Goods
Too Good To Go, an app that offers consumers cheap “surprise bags” of unsold food, is launching a new tool to help supermarkets discount expiring items.
-
To Cut Food Waste, Supermarkets Turn to AI to Sell Near-Expired Goods
Too Good To Go, an app that offers consumers cheap “surprise bags” of unsold food, is launching a new tool to help supermarkets discount expiring items.
-
King Frederik X Takes Danish Throne As Mother Abdicates
In King Frederik X, Danes will get a sovereign much unlike the one who’s reigned the country for the past five decades.
-
King Frederik X Takes Danish Throne As Mother Abdicates
In King Frederik X, Danes will get a sovereign much unlike the one who’s reigned the country for the past five decades.
-
Maersk Extends Red Sea Diversion And Warns Risks Will Persist
A.P. Moller-Maersk A/S plans to continue diverting ships away from the Red Sea “for the foreseeable future” after pausing transits earlier this week to assess the situation.
-
Shipping Giants Pause Red Sea Route As Houthi Attacks Intensify
Container shipping giant A.P. Moller-Maersk A/S instructed any ships heading for the southern entrance of the Red Sea to halt their voyages following an attack on one of its vessels and spiraling risks to the merchant fleet in the area posed by Houthi militants.
-
Shipping Giants Pause Red Sea Route As Houthi Attacks Intensify
Container shipping giant A.P. Moller-Maersk A/S instructed any ships heading for the southern entrance of the Red Sea to halt their voyages following an attack on one of its vessels and spiraling risks to the merchant fleet in the area posed by Houthi militants.
-
Ozempic Maker Novo Nordisk Invests $2.3 Billion In France Site
Novo Nordisk A/S, which faces supply bottlenecks amid high demand for its blockbuster weight-loss medicines, will invest €2.1 billion ($2.3 billion) to expand its production in France.
